Gastroenterology & Liver Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
J Gastrointestin Liver Dis. 2009 Sep;18(3):273-8.
In patients with obscure gastrointestinal bleeding (OGB), capsule endoscopy (CE) is the investigation of choice after negative conventional endoscopy. However, there is paucity of data on which clinical factors predict the ability of CE to detect pathology and alter management.
To investigate clinical factors which predict a higher diagnostic yield and a change in management in patients presenting with OGB.
Data was collected in patients with OGB for type of OGB [overt (OB) or iron deficiency anaemia (IDA)], co-morbidity, use of anticoagulants, transfusion dependence, subsequent CE diagnosis and follow up data. Factors that predicted a higher yield and a change in management were identified using logistic regression.
There were 427 patients (IDA 74%) with a mean age of 58 years (range 17-92).The diagnostic yield was 50% with a change in management in 30% of patients. The commonest finding was angiodysplasia in 52% of patients. There was no significant difference in the diagnostic yield between the two groups (OB: 56%, IDA 48%, p=0.15). On logistic regression, age (p=0.001), the use of warfarin (p=0.02) and liver co-morbidity (p=0.001) were significant factors which predicted a higher yield with CE. Factors which predicted a change in management included the presence of co-morbidity (p=0.02) and having a diagnosis of angiodysplasia on CE (p=0.001).
This is a large series of CE in OGB. Increasing age, anti-coagulation and liver co-morbidity are significant predictors of a positive diagnostic yield whilst the presence of co-morbidity or a diagnosis of angiodysplasia may predict a change in management.
在不明原因胃肠道出血(OGB)患者中,胶囊内镜(CE)是阴性常规内镜检查后的首选检查方法。然而,关于哪些临床因素可预测 CE 检测病理和改变治疗方案的能力的数据很少。
研究可预测 OGB 患者 CE 诊断率更高和治疗方案改变的临床因素。
对 OGB 患者[显性(OB)或缺铁性贫血(IDA)]的 OGB 类型、合并症、抗凝剂使用、输血依赖、随后的 CE 诊断和随访数据进行了数据收集。使用逻辑回归确定预测更高诊断率和改变治疗方案的因素。
共纳入 427 例 OGB 患者(IDA 占 74%),平均年龄为 58 岁(17-92 岁)。诊断率为 50%,30%的患者治疗方案发生改变。最常见的发现是血管发育不良占 52%。两组的诊断率无显著差异(OB:56%,IDA:48%,p=0.15)。Logistic 回归分析显示,年龄(p=0.001)、华法林使用(p=0.02)和肝脏合并症(p=0.001)是 CE 诊断率更高的显著预测因素。预测治疗方案改变的因素包括合并症(p=0.02)和 CE 诊断为血管发育不良(p=0.001)。
这是一项关于 OGB 中 CE 的大型研究。年龄增长、抗凝和肝脏合并症是阳性诊断率的显著预测因素,而合并症的存在或血管发育不良的诊断可能预示着治疗方案的改变。